AI-generated draft from CMS source. Review and verify clinical accuracy before use.
Authorization/Medical Necessity Workflow for CPT Code 64633 (Destruction by Neurolytic Agent, Cervical/Thoracic Facet Joint Nerve):
1. Confirm patient diagnosis:
– Verify diagnosis consistent with Medicare-covered indications such as cervical or thoracic facet joint pain due to spondylosis, ankylosing hyperostosis, or other specified dorsopathies (refer to ICD-10 codes M47.812-M53.84 and related).
– Not clearly stated in source if specific diagnostic imaging is mandatory prior to procedure; check local coverage determination (LCD L38801) for details.
2. Conservative Care Requirements:
– Not clearly stated in source material. Refer to LCD L38801 for conservative treatment trials if required before neurolytic destruction.
3. Diagnostic Criteria and Prior Procedures:
– Ensure prior facet joint diagnostic nerve blocks or therapeutic facet joint injections have been performed to identify pain generator.
– The initial diagnostic injections usually require KX modifier on claims; typically limited to two initial diagnostic injections.
– Document positive response to diagnostic blocks confirming target nerve(s) for neurolysis.
– Documentation required where patient is not a candidate for radiofrequency ablation (RFA) before proceeding with neurolytic agent destruction.
4. Procedure Level and Laterality Coding:
– 64633 reports single-level cervical or thoracic facet joint nerve destruction with imaging guidance (fluoroscopy or CT).
– Use 64634 for each additional cervical/thoracic facet joint.
– Bilateral procedures should append modifier -50. ASC facility billing must report separate lines with -RT and -LT modifiers.
– Denervation is reported per joint, not per nerve; one code per joint regardless of nerve count.
5. Imaging and Technique:
– Procedure must be performed under fluoroscopic or CT image guidance.
– Ultrasound guidance and non-thermal denervation techniques (e.g., chemical, pulsed radiofrequency) are not covered under these CPT codes.
– Moderate or deep sedation, general anesthesia, or MAC is not considered medically necessary for neurolytic agent destruction unless clearly documented as medically necessary.
6. Documentation Elements:
– Comprehensive assessment related to the patient’s pain complaint.
– Relevant medical history supporting facet joint pain diagnosis.
– Results and positive response to prior diagnostic injections.
– Operative report signed and dated by the performing provider documenting procedure details and rationale.
– Documentation explaining why patient is not a candidate for alternative therapies like RFA.
– For sedation use, separate documentation justifying medical necessity is required to avoid potential reviews.
7. Exclusion and Cautions:
– Use of non-covered codes for non-thermal denervation (e.g., CPT 64999) is not covered.
– Injection of biologicals or unauthorized substances into facet joints will cause entire claim denial.
– Multiple levels or nerves within the same joint must not be separately coded beyond allowed units per CPT guidelines.
8. Billing Notes for Audit-Ready Documentation:
Patient evaluated for cervical/thoracic facet joint pain consistent with Medicare-covered indications. Conservative treatment options have been considered (or attempted if applicable). Prior diagnostic facet injections performed with positive response confirming pain generator. Patient is not a candidate for radiofrequency ablation due to [insert reason]. Procedure performed under fluoroscopic/CT guidance with documented destruction of targeted facet joint nerve(s) at single joint level. Bilateral procedure performed (if applicable) with modifier 50 appended. Operative report and assessment documented and signed by performing provider. No moderate or deep sedation/general anesthesia used (or sedation justified as medically necessary).
Refer to LCD L38801 for additional criteria, frequency limits, and updates.
This CMS article (A58403, version 25) from the Medicare Coverage Database addresses billing and coding for facet joint interventions used in pain management, specifically for cervical/thoracic and lumbar facet joint procedures. It relates to the Local Coverage Determination (LCD) L38801, version 23, which contains detailed reasonable and necessary criteria including frequency limits. The contractor/MAC is not explicitly stated in the source.
The CPT/HCPCS codes discussed include diagnostic and therapeutic facet joint injections and neurolytic destruction of facet joint nerves (e.g., CPT codes 64490–64495 for injections and 64633–64636 for neurolytic destruction). Imaging guidance must be fluoroscopy or CT; ultrasound guidance is not covered. Codes for bilateral procedures should be reported with modifier 50. The KX modifier is required on claims for diagnostic injections to indicate medical necessity.
Covered ICD-10 diagnoses focus on spondylosis, ankylosing hyperostosis, and other specified dorsopathies affecting various spinal regions (cervical, thoracic, lumbar, sacral). There are no non-covered ICD-10 codes listed, but the policy prohibits coverage if biologicals or substances not designated for facet joint injections are used, resulting in claim denial per Medicare’s Benefit Policy Manual.
Moderate or deep sedation, general anesthesia, and monitored anesthesia care (MAC) are generally not considered reasonable during facet injections. For radiofrequency ablation and facet cyst aspiration/rupture, sedation or MAC may be covered if medical necessity is documented. Frequent combined billing of sedation with these procedures may prompt focused medical review.
Documentation requirements include thorough patient assessment relevant to the complaint, relevant past medical history, results of pertinent tests or procedures, and a signed and dated office visit or operative report. Claims without valid ICD-10 codes or appropriate documentation will be returned as incomplete or denied.
In summary, this article guides providers on correct coding practices, required modifiers, coverage limitations, and documentation needed for Medicare billing of facet joint interventions, emphasizing compliance with LCD L38801 and CMS coding edits to support claims for payment.